Union Health Secretary visits Bilthoven Biologicals, Netherlands
IMT News Desk
Discusses partnership and collaboration on production of vaccines, especially oral polio vaccineUnion Health Secretary Apurva Chandra visited the manufacturing unit of global pharmaceutical company Bilthoven Biologicals at Utrecht, Netherlands. He had an engaging meeting with CEO Juergen Kwik and CEO of Poonawalla Science Park (PSP) at Bilthoven Jef De Clercq on the EU pandemic preparedness partnership and collaboration on the production of vaccines. He met the senior management and was briefed on the various manufacturing units of the facility. A detailed presentation was made on their future manufacturing plans. Bilthoven Biologicals BV Co, manufactures pharmaceutical products such as vaccines for polio, diphtheria-tetanus-polio, and tetanus along with bacillus calmette-guerin (BCG).
